Journal of Practical Oncology ›› 2025, Vol. 39 ›› Issue (4): 330-337.doi: 10.11904/j.issn.1002-3070.2025.04.011
• Review • Previous Articles Next Articles
DAI Fengxue1, WANG Zhenfei2
Received:
2024-12-24
Revised:
2025-04-25
Published:
2025-09-09
CLC Number:
DAI Fengxue, WANG Zhenfei. Research progress on the potential role and mechanism of hydrogen sulfide in the treatment of gastric cancer[J]. Journal of Practical Oncology, 2025, 39(4): 330-337.
1 Bray F,Laversanne M,Sung H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263. 2 He F,Wang S,Zheng R,et al.Trends of gastric cancer burdens attributable to risk factors in China from 2000 to 2050[J].Lancet Reg Health West Pac,2024,44:101003. 3 Behar D,Boublenza L,Chabni N,et al.Retrospective epidemiological study on stomach cancer in a region of western Algeria:about 394 cases between 2011 and 2015[J].J Gastrointest Cancer,2021,52(2):706-710. 4 Kang SY,Hwang D,Shin S,et al.Potential of bioactive food components against gastric cancer:Insights into molecular mechanism and therapeutic targets[J].Cancers(Basel),2021,13(18):4502. 5 Zuhra K,Tomé CS,Forte E,et al.The multifaceted roles of sulfane sulfur species in cancer-associated processes[J].Biochim Biophys Acta Bioenerg,2021,1862(2):148338. 6 Xu Z,Zhu Y,Xie M,et al.Mackinawite nanozymes as reactive oxygen species scavengers for acute kidney injury alleviation[J].J Nanobiotechnology,2023,21(1):281. 7 Bełtowski J.Synthesis,metabolism,and signaling mechanisms of hydrogen sulfide:an overview[J].Methods Mol Biol,2019,2007:1-8. 8 Mini P,Walker SE,Grace MR,et al.Detection of aqueous and gaseous hydrogen sulfide with lanthanide-macrocycle binary complexes[J].Dalton Trans,2023,52(35):12235-12243. 9 Tabassum R,Jeong NY,Jung J.Protective effect of hydrogen sulfide on oxidative stress-induced neurodegenerative diseases[J].Neural Regen Res,2020,15(2):232-241. 10 Bhadwal SS,Verma S,Hassan S,et al.Unraveling the potential of hydrogen sulfide as a signaling molecule for plant development and environmental stress responses:a state-of-the-art review[J].Plant Physiol Biochem,2024,212:108730. 11 Kolluru GK,Shen X,Kevil CG.Reactive sulfur species:a new redox player in cardiovascular pathophysiology[J].Arterioscler Thromb Vasc Biol,2020,40(4):874-884. 12 Alsaeedi A,Welham S,Rose P,et al.The impact of drugs on hydrogen sulfide homeostasis in mammals[J].Antioxidants(Basel),2023,12(4):908. 13 Fukuto JM,Vega VS,Works C,et al.The chemical biology of hydrogen sulfide and related hydropersulfides:interactions with biologically relevant metals and metalloproteins[J].Curr Opin Chem Biol,2020,55:52-58. 14 Yang Z,Wang X,Feng J,et al.Biological functions of hydrogen sulfide in plants[J].Int J Mol Sci,2022,23(23):15107. 15 Jiang Z,Liu D,Li T,et al.Hydrogen sulfide reduces oxidative stress in Huntington′s disease via Nrf2[J].Neural Regen Res,2025,20(6):1776-1788. 16 Shen J,Zhai J,You Q,et al.Cancer-associated fibroblasts-derived VCAM1 induced by H.pylori infection facilitates tumor invasion in gastric cancer[J].Oncogene,2020,39(14):2961-2974. 17 Li X,Zhu S,Zhang T,et al.Association between oral microflora and gastrointestinal tumors(Review)[J].Oncol Rep,2021,46(2):160. 18 Li H,Guan B,Liu S,et al.PTPN14 promotes gastric cancer progression by PI3KA/AKT/mTOR pathway[J].Cell Death Dis,2023,14(3):188. 19 Chen R,Yang M,Huang W,et al.Cascades between miRNAs,lncRNAs and the NF-κB signaling pathway in gastric cancer(Review)[J].Exp Ther Med,2021,22(1):769. 20 Zeng Z,Yang B,Liao Z.Progress and prospects of immune checkpoint inhibitors in advanced gastric cancer[J].Future Oncol,2021,17(12):1553-1569. 21 Cen S,Xu H,Liu Z,et al.Immune microenvironment characteristics and their implications for immune checkpoint inhibitor efficacy in HER2-overexpressing gastric cancer[J].Clin Exp Immunol,2022,207(3):318-328. 22 Zeng Z,Zhu Q.Progress and prospects of biomarker-based targeted therapy and immune checkpoint inhibitors in advanced gastric cancer[J].Front Oncol,2024,14:1382183. 23 Li J,Zhang H,Bei S,et al.Disruption of wnt/β-catenin pathway elevates the sensitivity of gastric cancer cells to PD-1 antibody[J].Curr Mol Pharmacol,2022,15(3):557-569. 24 Kumagai S,Togashi Y,Sakai C,et al.An oncogenic alteration creates a microenvironment that promotes tumor progression by conferring a metabolic advantage to regulatory T cells[J].Immunity,2020,53(1):187-203.e188. 25 Bagheri M,Akrami H.Studying the non-coding RNA expression and its role in drug resistance mechanisms of gastric cancer[J].Pathol Res Pract,2025,265:155742. 26 Cui MY,Yi X,Zhu DX,et al.The role of lipid metabolism in gastric cancer[J].Front Oncol,2022,12:916661. 27 Huang Y,Liang L,Zhao YX,et al.RUNX2 reverses p53-induced chemotherapy resistance in gastric cancer[J].Pharmgenomics Pers Med,2023,16:253-261. 28 Wang R,Tao B,Fan Q,et al.Fatty-acid receptor CD36 functions as a hydrogen sulfide-targeted receptor with its Cys333-Cys272 disulfide bond serving as a specific molecular switch to accelerate gastric cancer metastasis[J].EBioMedicine,2019,45:108-123. 29 Kawahara Y,Hirashita Y,Tamura C,et al.Helicobacter pylori infection modulates endogenous hydrogen sulfide production in gastric cancer AGS cells[J].Helicobacter,2020,25(5):e12732. 30 Ma W,Zhang X,Zhuang L.Exogenous hydrogen sulfide induces A375 melanoma cell apoptosis through overactivation of the unfolded protein response[J].Clin Cosmet Investig Dermatol,2023,16:1641-1651. 31 Wang H,Li X,Zhu Z,et al.Hydrogen sulfide promotes lipopolysaccharide-induced apoptosis of osteoblasts by inhibiting the Akt/NF-κB signaling pathway[J].Biochem Biophys Res Commun,2020,524(4):832-838. 32 Padmanabhan N,Kyon HK,Boot A,et al.Author correction:highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation[J].Genome Biol,2021,22(1):181. 33 Ye F,Li X,Sun K,et al.Inhibition of endogenous hydrogen sulfide biosynthesis enhances the anti-cancer effect of 3,3′-diindolylmethane in human gastric cancer cells[J].Life Sci,2020,261:118348. 34 Cui Q,Yang Y,Ji N,et al.Gaseous signaling molecules and their application in resistant cancer treatment:from invisible to visible[J].Future Med Chem,2019,11(4):323-336. 35 Tian L,Pei R,Zhang X,et al.Tumor cell-specific and lipase-responsive delivery of hydrogen sulfide for sensitizing chemotherapy of pancreatic cancer[J].Front Bioeng Biotechnol,2022,10:934151. 36 Liang X,Kurboniyon MS,Zou Y,et al.GSH-triggered/photothermal-enhanced H(2)S signaling molecule release for gas therapy[J].Pharmaceutics,2023,15(10):2443. 37 Li J,Xie L,Sang W,et al.A metal-phenolic nanosensitizer performs hydrogen sulfide-reprogrammed oxygen metabolism for cancer radiotherapy intensification and immunogenicity[J].Angew Chem Int Ed Engl,2022,61(18):e202200830. 38 Liu C,Zhang Y,Sun W,et al.H(2)S-activated fluorescent probe enables dual-channel fluorescence tracking of drug release in tumor cells[J].Bioorg Chem,2023,135:106498. 39 Yang XY,Luo ZQ,Fang D,et al.Hollow copper sulfide nanocubes loaded with pt(IV)complexes for cancer multimodal therapy[J].Langmuir,2024,40(43):22875-22886. 40 Wang K,Li Y,Wang X,et al.Gas therapy potentiates aggregation-induced emission luminogen-based photoimmunotherapy of poorly immunogenic tumors through cGAS-STING pathway activation[J].Nat Commun,2023,14(1):2950. 41 Li M,Liu Y,Zhang Y,et al.Sono-activatable semiconducting polymer nanoreshapers multiply remodel tumor microenvironment for potent immunotherapy of orthotopic pancreatic cancer[J].Adv Sci(Weinh),2023,10(35):e2305150. 42 Sun M,Wang T,Zhu Y,et al.Gas immnuo-nanomedicines fight cancers[J].Biomed Pharmacother,2024,180:117595. 43 Paul BD,Snyder SH,Kashfi K.Effects of hydrogen sulfide on mitochondrial function and cellular bioenergetics[J].Redox Biol,2021,38:101772. 44 Zhang G,Wang G,Zhou Y,et al.Simultaneous use of nitrate and calcium peroxide to control sulfide and greenhouse gas emission in sewers[J].Sci Total Environ,2023,855:158913. 45 Al-Jassim M,Frazier T,Wood E.Emergency management and HAZMAT mitigation:Strategic planning for new developments[J].J Emerg Manag,2023,20(8):39-57. 46 Mahato SK,Barman P,Badirujjaman M,et al.Cysteine-responsive prodrug of the anti-cancer drug amonafide:fluorogenic adjuvant drug delivery with hydrogen sulfide(H2S)[J].Chem Commun(Camb),2023,59(32):4802-4805. 47 Yuan T,Hashimoto K,Tazaki A,et al.Potential application of a hydrotalcite-like compound for reduction of toxicity to aquatic organisms via rapid and efficient removal of hydrogen sulfide[J].J Environ Manage,2022,321:115861. 48 Pan Y,Huang Z,Zheng D,et al.Interface engineering of sandwich SiO(2)@α-Fe(2)O(3)@COF core-shell S-scheme heterojunctions for efficient photocatalytic oxidation of gas-phase H2S[J].J Colloid Interface Sci,2023,644:19-28. 49 Park J,Kang T,Heo Y,et al.Evaluation of short-term exposure levels on ammonia and hydrogen sulfide during manure-handling processes at livestock farms[J].Saf Health Work,2020,11(1):109-117. 50 Santos SL,Holz C,Milleman K,et al.Effectiveness of a combination of laccase and green coffee extract on oral malodor:a comparative,randomized,controlled,evaluator-blind,parallel-group trial[J].J Breath Res,2024,19(1):10. 51 Yu JG,Li N,Wang Z,et al.Dual modulating effects of hydrogen sulfide on gastrointestinal tract and efficacy-toxicity transformation of hydrogen sulfide-mediated drugs[J].Zhongguo Zhong Yao Za Zhi,2022,47(15):3986-3993. 52 Wu D,Hu Q,Ma F,et al.Vasorelaxant effect of a new hydrogen sulfide-nitric oxide conjugated donor in isolated rat aortic rings through cGMP pathway[J].Oxid Med Cell Longev,2016,2016:7075682. 53 Li C,Hu M,Wang Y,et al.Hydrogen sulfide preconditioning protects against myocardial ischemia/reperfusion injury in rats through inhibition of endo/sarcoplasmic reticulum stress[J].Int J Clin Exp Pathol,2015,8(7):7740-7751. 54 Gao X,Li HN,Liu PJ,et al.Synthesis of sinomenine derivatives with potential anti-leukemia activity[J].J Asian Nat Prod Res,2024:1-17. 55 Pandey T,Pandey V.Advancements in increasing efficiency of hydrogen sulfide in therapeutics:strategies for targeted delivery as prodrugs[J].Nitric Oxide,2024,152:1-10. 56 Özatik FY,Özatik O,Tekşen Y,et al.Dose-dependent effect of hydrogen sulfide in cyclophosphamide-induced hepatotoxicity in rats[J].Turk J Gastroenterol,2023,34(6):626-634. 57 Hooshmand S,Kassanos P,Keshavarz M,et al.Wearable nano-based gas sensors for environmental monitoring and encountered challenges in optimization[J].Sensors(Basel),2023,23(20):8648. 58 Polhemus DJ,Li Z,Pattillo CB,et al.A novel hydrogen sulfide prodrug,SG1002,promotes hydrogen sulfide and nitric oxide bioavailability in heart failure patients[J].Cardiovasc Ther,2015,33(4):216-226. 59 Lancia M,Panata L,Tondi V,et al.A fatal work-related poisoning by hydrogen sulfide:report on a case[J].Am J Forensic Med Pathol,2013,34(4):315-317. 60 Vales A,Coyle C,Plehhova K,et al.Randomised clinical trial:the use of alginates during preinvestigation proton pump inhibitor wash-out and their impact on compliance and symptom burden[J].BMJ Open Gastroenterol,2023,10(1):e001026. 61 Stoppa G,Nuvolone D,Petri D,et al.Exposure to low levels of hydrogen sulphide and its impact on chronic obstructive pulmonary disease and lung function in the geothermal area of mt.amiata in italy:the cross-sectional inVETTA study[J].PLoS One,2023,18(11):e0293619. 62 Zong Y,Tanaka M,Muramatsu M,et al.D-amino acid oxidase(DAO)rare genetic missense variant p.pro103leu and gastric cancer[J].Mol Clin Oncol,2021,14(3):58. 63 Szponarski M,Gademann K.Antibody recognition of cancer cells via glycan surface engineering[J].Chembiochem,2022,23(15):e202200125. 64 Tian Q,Wang X,Song S,et al.Engineering of an endogenous hydrogen sulfide responsive smart agent for photoacoustic imaging-guided combination of photothermal therapy and chemotherapy for colon cancer[J].J Adv Res,2022,41:159-168. 65 Zhao Y,Steiger AK,Pluth MD.Cyclic sulfenyl thiocarbamates release carbonyl sulfide and hydrogen sulfide independently in thiol-promoted pathways[J].J Am Chem Soc,2019,141(34):13610-13618. 66 Liu J,Tian R,Sun C,et al.Microbial metabolites are involved in tumorigenesis and development by regulating immune responses[J].Front Immunol,2023,14:1290414. 67 Wang Z,Wang Y.Hydrogen sulfide:a rising star for cancer treatment[J].Med Gas Res,2025,15(1):114-116. 68 Bazzal AA,Hoteit BH,Chokor M,et al.Potential therapeutic applications of medical gases in cancer treatment[J].Med Gas Res,2025,15(2):309-317. 69 Majumder A.Targeting homocysteine and hydrogen sulfide balance as future therapeutics in cancer treatment[J].Antioxidants(Basel),2023,12(8):1520. |
[1] | CHEN Lijuan, MA Xinxin, GAO Guangqiang, TIAN Hong, LIU Jiaren. Research on the mechanism of dihydroactiniolide in inhibiting the proliferation of gastric cancer cells [J]. Journal of Practical Oncology, 2025, 39(2): 91-98. |
[2] | MA Ming, WANG Wanying, RUAN Yuli, LIU Chao, ZHANG Yanqiao, MA Zhigang. The values of systemic inflammatory immune nutritional score in predicting the prognosis of immunotherapy for advanced gastric cancer [J]. Journal of Practical Oncology, 2025, 39(1): 39-48. |
[3] | KONG Hongqian, DONG Juan, WEN Hongmei, SHAO Ying, CHENG Huirong, YU Qiuli. Analysis of gastric cancer incidence and mortality in cancer registration areas of Yunnan province in 2020 and the trends from 2012 to 2020 [J]. Journal of Practical Oncology, 2024, 38(6): 372-376. |
[4] | LIAO Jun, LI Chunfeng, XUE Yingwei, ZU Hongliang. Research progress of lactate dehydrogenase in the diagnosis and treatment of gastric cancer [J]. Journal of Practical Oncology, 2024, 38(3): 200-206. |
[5] | YANG Peng, LUO Jinmei, LUO Ping, XIE Xiaobo. An immune score model based on immune cell infiltration predicts the effects of immunotherapy and prognosis of early gastric cancer [J]. Journal of Practical Oncology, 2024, 38(2): 121-130. |
[6] | GAO Chaofeng, ZHAO Zekun, WEI Fengxian, SUN Yuan, ZHOU Zhiming, XU Xiaodong. Research progress on perioperative nutritional management for gastric cancer [J]. Journal of Practical Oncology, 2023, 37(6): 519-523. |
[7] | FU Xinya, HU Lingdan, ZHANG Zhijian, MA Xiumei. HPA promotes the invasion and metastasis of human gastric cancer cells by up-regulating MCP1/CCR2 [J]. Journal of Practical Oncology, 2023, 37(4): 329-336. |
[8] | LI Juan, LIU Jiaren. The current research status and progress of immunotherapy for gastric cancer [J]. Journal of Practical Oncology, 2023, 37(4): 372-376. |
[9] | MING Cheng, WU Yun. Research progress of Wnt/β-catenin signaling pathway and its inhibitors in gastric cancer [J]. Journal of Practical Oncology, 2023, 37(2): 190-194. |
[10] | YANG Ju, LIU Qin, LIU Baorui, WEI Jia. Gastric cancer-associated cancer-testis antigen screening and immune infiltration analysis [J]. Journal of Practical Oncology, 2022, 36(6): 495-501. |
[11] | XU Wei, LIU Haipeng, WANG Wenjie, WANG Zhou, LI Yuanyuan, SHEN Yimin, CHEN Xiao. Research progress on the causes and prevention measures of cholecystolithiasis after gastric cancer surgery [J]. Journal of Practical Oncology, 2022, 36(6): 561-565. |
[12] | ZHAO Yaru, WU Yun. Research status of common biomarkers and corresponding targeted therapy for gastric cancer [J]. Journal of Practical Oncology, 2022, 36(5): 483-488. |
[13] | ZHI Lianghui, LIU Wei, LI Wei, ZHEN Sihu, JIAO Xilin. Mechanism of lncRNA-ATB mediated epithelial mesenchymal transition in the progression of gastric cancer [J]. Journal of Practical Oncology, 2022, 36(3): 208-213. |
[14] | WANG Hongying, LI Yan, HAN Xinhao, WEI Xiaoli, JIA Huixun, YUAN Wenjuan, ZHANG Qiuju. Construction and validation of a risk model for early diagnosis and prognosis of gastric cancer based on immune-related lncRNAs [J]. Journal of Practical Oncology, 2022, 36(2): 119-126. |
[15] | ZHAO Baoshan, LIANG Guanying, XU Shengjie, QIAO Hui, CHEN Hongxia, MA Ying, JU Xueping, WANG Lin. Analysis of the correlation between PELP1 expression and gastric cancer progression and prognosis [J]. Journal of Practical Oncology, 2022, 36(1): 31-36. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||